CHM chimeric therapeutics limited

Ann: Completion of Entitlement Offer, page-26

  1. 3,136 Posts.
    lightbulb Created with Sketch. 1749
    Agree.

    Since the 16th December when they announced that CORE-NK was moving to frontline treatment, they have dosed ONE patient.

    One out of 20.

    And with the CHM CDH-17 - they dosed one patient in this last quarter.

    With a cash-burn rate of @ $4 per quarter, it's just not sustainable.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $412 93K

Buyers (Bids)

No. Vol. Price($)
25 21633206 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 23899303 29
View Market Depth
Last trade - 12.45pm 16/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.